#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3084	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2307	237.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1805	1805	T	310	T,C	179,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3084	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2307	237.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1539	1539	C	333	C	193	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3084	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2307	237.0	0	HET	.	.	.	A69G	.	69	69	A	424	424	A	280	A,G	126,46	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5600	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3384	285.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1528	1528	A	286	A	184	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5600	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3384	285.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2162	2162	C	267	C,A	157,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5600	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3384	285.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2788	2788	T	307	T,C	134,53	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5600	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3384	285.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2236	2236	A	289	A	173	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	234	folP	852	852	99.88	folP.l15.c4.ctg.1	1480	27.0	0	.	p	.	0	E151K	NONSYN	451	453	GAA	712	714	AAA	45;45;45	A;A;A	27;26;27	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	234	folP	852	852	99.88	folP.l15.c4.ctg.1	1480	27.0	1	SNP	p	R228S	1	.	.	682	684	AGC	943	945	AGC	31;31;30	A;G;C	20;18;21	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	690	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3208	38.1	1	SNP	p	S91F	0	.	.	271	273	TCC	483	485	TCC	44;44;44	T;C;C	27;27;27	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	690	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3208	38.1	1	SNP	p	D95G	0	.	.	283	285	GAC	495	497	GAC	45;48;49	G;A;C	26;29;28	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	690	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3208	38.1	1	SNP	p	D95N	0	.	.	283	285	GAC	495	497	GAC	45;48;49	G;A;C	26;29;28	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	212	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1290	31.2	1	SNP	p	G45D	0	.	.	133	135	GGC	466	468	GGC	65;65;65	G;G;C	39;39;40	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	150	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	632	40.0	0	.	n	.	0	A197.	DEL	197	197	A	305	305	A	61	A	37	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	608	parC	2304	2304	99.91	parC.l15.c17.ctg.1	2952	36.6	1	SNP	p	D86N	0	.	.	256	258	GAC	422	424	GAC	48;48;48	G;A;C	32;30;29	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	608	parC	2304	2304	99.91	parC.l15.c17.ctg.1	2952	36.6	1	SNP	p	S87R	0	.	.	259	261	AGT	425	427	AGT	48;50;52	A;G;T	28;32;34	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	608	parC	2304	2304	99.91	parC.l15.c17.ctg.1	2952	36.6	1	SNP	p	S87W	0	.	.	259	261	AGT	425	427	AGT	48;50;52	A;G;T	28;32;34	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	608	parC	2304	2304	99.91	parC.l15.c17.ctg.1	2952	36.6	1	SNP	p	S87I	0	.	.	259	261	AGT	425	427	AGT	48;50;52	A;G;T	28;32;34	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	608	parC	2304	2304	99.91	parC.l15.c17.ctg.1	2952	36.6	1	SNP	p	S88P	0	.	.	262	264	TCC	428	430	TCC	52;53;53	T;C;C	37;36;35	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	540	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2583	38.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1535	1537	GGC	31;31;31	G;G;C	22;22;19	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	592	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2201	47.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1300	1302	GCA	79;82;82	G;C;A	47;49;48	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	592	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2201	47.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1303	1305	ATC	82;82;84	A;T;C	48;48;49	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	592	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2201	47.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1315	1317	GTG	81;81;81	G;T;G	49;46;48	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	592	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2201	47.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1315	1317	GTG	81;81;81	G;T;G	49;46;48	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	592	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2201	47.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1819	1821	ACC	39;38;37	A,C;C;C	26,1;25;26	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	592	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2201	47.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1873	1875	GCG	24;24;24	G;C;G,T	14;15;14,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	592	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2201	47.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1873	1875	GCG	24;24;24	G;C;G,T	14;15;14,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	592	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2201	47.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1996	1998	GGC	38;38;37	G;G;C	21;25;20	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	592	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2201	47.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2005	2007	GGC	37;37;35	G;G;C	22;24;18	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	592	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2201	47.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2023	2025	CTG	36;37;37	C;T;G	18;18;17	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	263	944	ponA	2397	2388	100.0	ponA.l15.c4.ctg.1	2781	48.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1654	1656	CCG	37;36;36	C;C;G	22;23;22	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	263	944	ponA	2397	202	100.0	ponA.l15.c4.ctg.2	443	22.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	263	944	ponA	2397	225	100.0	ponA.l15.c4.ctg.3	470	9.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	346	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1687	36.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	580	580	C	19	C	9	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1314	43.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	179	181	GAA	52;51;53	G;A;A	29;28;30	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1314	43.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	467	469	GAT	42;43;43	G;A;T	27;28;27	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1314	43.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	590	592	TCA	59;59;59	T,G;C;A	33,1;33;35	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1314	43.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	719	721	GTC	47;48;50	G;T;C	28;29;30	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1314	43.2	1	SNP	p	G120K	1	.	.	358	360	AAG	425	427	AAG	51;51;51	A;A;G	30;30;31	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1314	43.2	1	SNP	p	A121D	1	.	.	361	363	GAC	428	430	GAC	51;51;51	G;A;C	30;29;30	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1314	43.2	1	SNP	p	D121N	0	.	.	361	363	GAC	428	430	GAC	51;51;51	G;A;C	30;29;30	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1608	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4624	61.2	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1835	1837	AAT	68;70;70	A;A;T	41;43;43	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	158	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	916	35.2	1	SNP	p	V57M	1	.	.	169	171	ATG	498	500	ATG	61;61;64	A;T;G	38;38;40	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
